Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.53 |
| ▸ | TUBB | P07437 | 1/20 | 0.53 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.53 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.53 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.53 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.53 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.53 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.53 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.53 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.53 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.53 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.53 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.53 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.53 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8533124 | 1.00 | GAA (0.60) | GAAMEN1KMT2APTGS2TUBB4A | |
| SCHEMBL8026574 | 1.00 | GAA (0.60) | GAAMEN1KMT2APTGS2TUBB4A | |
| Hydrochloric Acid SCHEMBL8027086 | 0.98 | GAA (0.63) | GAAMEN1KMT2APTGS2TUBB4A | |
| Hydrochloric Acid SCHEMBL8409806 | 0.98 | GAA (0.63) | GAAMEN1KMT2APTGS2TUBB4A | |
| Hydrochloric Acid SCHEMBL8407992 | 0.98 | GAA (0.63) | GAAMEN1KMT2APTGS2TUBB4A | |
| SCHEMBL207179 | 0.98 | GAA (0.62) | GAAMEN1KMT2APTGS2TUBB4A | |
| Hydrochloric Acid SCHEMBL8410665 | 0.96 | GAA (0.65) | GAAMEN1KMT2APTGS2TUBB4A | |
| SCHEMBL8026568 | 0.91 | GAA (0.55) | GAAMEN1KMT2APTGS2TUBB4A | |
| SCHEMBL8531035 | 0.90 | GAA (0.58) | GAAMEN1KMT2APTGS2TUBB4A | |
| SCHEMBL9542251 | 0.90 | GAA (0.71) | GAAMEN1KMT2APTGS2TUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030224028-A1 | Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal | SOCIETE L'OREAL S.A. (FR) | 2003-12-04 | — | — | US | claimed |
| EP-1364641-A1 | Use of at least one metal complex as a desquamative agent | L'OREAL (FR) | 2003-11-26 | — | — | EP | claimed |
| EP-0816324-B1 | Subsituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions | OREAL (FR) | 2000-02-16 | — | — | EP | claimed |
| EP-0816324-A1 | Subsituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions | L'OREAL (FR) | 1998-01-07 | — | — | EP | claimed |
| US-20030224028-A1 | Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal | SOCIETE L'OREAL S.A. (FR) | 2003-12-04 | — | — | US | disclosed |
| EP-1364641-A1 | Use of at least one metal complex as a desquamative agent | L'OREAL (FR) | 2003-11-26 | — | — | EP | disclosed |
| EP-0816324-B1 | Subsituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions | OREAL (FR) | 2000-02-16 | — | — | EP | disclosed |
| US-5910513-A | PROTECTING THE BODY AGAINST OXIDATIVE STRESS SUCH AS NEURODEGENERATIVE DISEASES, PARKINSON'S DISEASE, CHRONIC INFLAMMATORY CONDITIONS, REINFUSION ISCHAEMIA SYNDROME, THE TOXICITY OF CERTAIN DRUGS SUCH AS CERTAIN XENOBIOTICS | L'OREAL (FR) | 1999-06-08 | — | — | US | disclosed |
| EP-0816324-A1 | Subsituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions | L'OREAL (FR) | 1998-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224028-A1 | Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal | MC1R, LGMN, CUTA | GAA 640/4885MEN1 1745/4885KMT2A 3756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.